CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-02-19 | QUICK THOMAS C Director | Purchase · Common Stock Warrant | +65,309 | 251,041 | ||
| 2010-02-19 | QUICK THOMAS C Director | Purchase · Common Stock Warrant | +43,539 | 294,580 | ||
| 2010-02-19 | QUICK THOMAS C Director | Purchase · Common Stock Warrant | +65,309 | 359,889 | ||
| 2010-02-19 | QUICK THOMAS C Director | Purchase · Common Stock Warrant | +43,539 | 403,428 | ||
| 2010-02-19 | QUICK THOMAS C Director | Purchase · Convertible Debenture Due 12/31/2010 | +0 | 1,163,004 | ||
| 2010-02-19 | Isabelle Warren John Director | Purchase | +16,745 | 18,967 | ||
| 2010-02-19 | Isabelle Warren John Director | Purchase · Common Stock Warrant | +9,691 | 13,719 | ||
| 2010-02-19 | Isabelle Warren John Director | Purchase · Common Stock Warrant | +16,152 | 29,871 | ||
| 2010-02-19 | Isabelle Warren John Director | Purchase · Common Stock Warrant | +10,768 | 40,639 | ||
| 2010-02-19 | Isabelle Warren John Director | Purchase · Common Stock Warrant | +16,152 | 56,791 | ||
| 2010-02-19 | Isabelle Warren John Director | Purchase · Common Stock Warrant | +10,768 | 67,559 | ||
| 2010-02-19 | Isabelle Warren John Director | Purchase · Convertible Debenture Due 12/31/2010 | +0 | 287,626 | ||
| 2010-02-19 | FORBES CHRISTOPHER Director | Purchase · Common Stock Warrant | +510,676 | 1,129,399 | ||
| 2010-02-19 | FORBES CHRISTOPHER Director | Purchase · Common Stock Warrant | +851,123 | 1,980,522 | ||
| 2010-02-19 | FORBES CHRISTOPHER Director | Purchase · Common Stock Warrant | +567,416 | 2,547,938 | ||
| 2010-02-19 | FORBES CHRISTOPHER Director | Purchase · Common Stock Warrant | +851,123 | 3,399,061 | ||
| 2010-02-19 | FORBES CHRISTOPHER Director | Purchase · Common Stock Warrant | +567,416 | 3,966,477 | ||
| 2010-02-19 | FORBES CHRISTOPHER Director | Purchase · Convertible Debenture Due 12/31/2010 | +0 | 15,156,574 | ||
| 2010-02-19 | BRACA JOHN N Director | Purchase | +16,745 | 53,167 | ||
| 2010-02-19 | BRACA JOHN N Director | Purchase · Common Stock Warrant | +9,691 | 18,719 |
Page 33 of 38 · 754 trades